drugset / Trial / NCT03080740

The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis

NCT03080740

Phase 4 Unknown 300 enrolled Guangzhou Yipinhong Pharmaceutical CO.,LTD
RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized, double blind, positive drug parallel comparison, multi-centre clinical trial to assess the Efficacy and Safety of Clindamycin palmitate hydrochloride dispersible tablet for the treatment of bacterial vaginosis

Timeline

Start
2016-07
Primary completion
2017-07
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clindamycin Unknown 300 mg Oral
Comparator Metronidazole Small molecule 400 mg Oral

Indications